Keywords: Charles River, WuXi, Merger cancelled, Pfizer, Idun, Conatus

Charles River calls off WuXi Pharmatech buy on shareholder opposition; Pfizer sells Idun to Conatus

Article | 02 August 2010

US medical research equipment and services company Charles River Laboratories International said Friday it is canceling a $1.6 billion acquisition of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

WuXi Apptec

Pfizer

Idun Pharmaceuticals

Charles River Laboratories

Conatus Pharmaceuticals

Go to company listing